Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| Switzerland | CHF | Delayed | ||
| BATS Europe | CHF | Delayed | ||
| BATS Europe | EUR | Delayed | ||
| NYSE | USD | Real-time | ||
| OTC Markets | USD | Delayed | ||
| London | CHF | Real-time | ||
| Mexico | MXN | Delayed | ||
| Milan | EUR | Real-time | ||
| TradeGate | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Moscow | RUB | Real-time |
Gainers:Midatech Pharma (MTP) +33%. Cellect Biotechnology (APOP) +31%. Losers: United Time Technology (UTME) -66%.CureVac (CVAC) -38%.Gaucho Group (VINO) -30%.
Artios' small molecule Polθ inhibitor elicits BRCA-gene synthetic lethality and PARP inhibitor synergyGenetic screening reveals biomarkers within the PARP inhibitor resistance...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Neutral | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Sell | Strong Buy | Strong Buy |
| Summary | Strong Sell | Strong Sell | Neutral | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,395.00 | 1,435.00 | 1,395.00 | -35.00 | -2.45% | 59.60K | London | |||
| 198.72 | 203.00 | 195.06 | -1.58 | -0.79% | 36.33M | London | |||
| 337.50 | 338.00 | 329.50 | +4.50 | +1.35% | 1.23M | London | |||
| 0.0225 | 0.00 | 0.00 | 0.0000 | 0.00% | 0.00 | London | |||
| 107.52 | 112.20 | 106.70 | -4.40 | -3.93% | 50.94M | London | |||
| 1,190.50 | 1,218.50 | 1,184.50 | -29.00 | -2.38% | 4.05M | London | |||
| 192.24 | 198.10 | 191.68 | -2.18 | -1.12% | 3.02M | London | |||
| 396.00 | 405.50 | 393.80 | 0.00 | 0.00% | 0.00 | London | |||
| 266.00 | 270.00 | 264.60 | -0.80 | -0.30% | 1.51M | London | |||
| 171.86 | 177.72 | 171.74 | -6.96 | -3.89% | 97.46M | London | |||
| 723.00 | 732.00 | 716.00 | -2.00 | -0.28% | 908.00 | London | |||
| 3,369.00 | 3,482.00 | 3,349.00 | -85.0 | -2.46% | 457.03K | London | |||
| 634.40 | 668.60 | 632.60 | -18.40 | -2.82% | 764.44K | London | |||
| 1.50 | 1.30 | 1.30 | 0.000 | 0.00% | 0.00 | London | |||
| 264.14 | 264.14 | 260.00 | +0.14 | +0.05% | 5.30K | London |
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.